Cargando…
Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris
Coronary heart disease is a global malady and it is the leading cause of death in the United States. Chronic stable angina is the most common manifestation of coronary heart disease and it results from the imbalance between myocardial oxygen supply and demand due to reduction in coronary blood flow....
Autores principales: | Aldakkak, Mohammed, Stowe, David F., Camara, Amadou K.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932785/ https://www.ncbi.nlm.nih.gov/pubmed/24574825 http://dx.doi.org/10.4137/CMT.S7824 |
Ejemplares similares
-
Comparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectoris
por: Chaturvedi, Aditi, et al.
Publicado: (2013) -
Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study
por: Kourlaba, Georgia, et al.
Publicado: (2015) -
Utility of ranolazine in chronic stable angina patients
por: Patel, Pawan D, et al.
Publicado: (2008) -
Update on ranolazine in the management of angina
por: Codolosa, J Nicolás, et al.
Publicado: (2014) -
Ranolazine for Angina in Hypertrophic Cardiomyopathy
por: Amin, Akhtar, et al.
Publicado: (2018)